2020 Insights Into The U.S. Rosacea Market: Profiles Of Key Players Including Allergan, Galderma And Sol-Gel Technologies

DUBLIN, May 14, 2020 /PRNewswire/ -- The "The U.S.
Author:
Publish date:

DUBLIN, May 14, 2020 /PRNewswire/ -- The "The U.S. Rosacea Market: Size, Trends & Forecasts (2020-2024 Edition)" report has been added to ResearchAndMarkets.com's offering.

This report provides a detailed analysis of the U.S. rosacea market with market sizing and growth pattern. The analysis includes the rosacea market in terms of value, volume and number of patients seeking treatment. The report also provides an overview of the U.S. dermatology drugs market in terms of value and market share by segments.Furthermore, the report also assesses the key opportunities available in the market and summarizes the dynamic forces that are and will be accountable for the growth of the industry. Growth of the U.S. rosacea market has also been forecasted for the period 2020-2024, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.Foamix Pharmaceuticals Ltd., Galderma, Sol-Gel Technologies Ltd., and Allergan Plc are some of the major players whose company profiling has been done in the report. This segment of the report summarizes business overview, financial overview and the business strategies adopted by respective companies.The U.S. rosacea market has grown over the past few years and is projected to grow at a high growth rate on the back of rising incidence of disease, and aging population. The growth in the market will be driven by unhealthy eating habits and environmental factors, rising disposable income, ageing population, escalating healthcare expenditure, high prevalence of rosacea, etc. Yet the market growth is restrained by factors such as lack of awareness and knowledge and stringent government regulations for the approval of new drugs.

Key Topics Covered:

1. Executive Summary 2. Introduction2.1 Overview of Rosacea2.1.1 Symptoms of Rosacea2.1.2 Causes of Rosacea2.1.3 Types of Rosacea2.1.4 Treatment of Rosacea 3. The U.S. Market Analysis3.1 The U.S. Dermatology Drugs Market Analysis3.1.1 The U.S. Dermatology Drugs Market by Value3.1.2 The U.S. Dermatology Drugs Market by Segments (Rosacea and Other)3.2 The U.S. Rosacea Market Analysis3.2.1 The U.S. Rosacea Market by Value3.2.2 The U.S. Rosacea Market by Volume3.2.3 The U.S. Rosacea Market by Number of Patients Seeking Treatment 4. Market Dynamics4.1 Growth Drivers4.1.1 Aging Population4.1.2 Rising Disposable Personal Income4.1.3 Escalating Healthcare Expenditure4.1.4 Unhealthy Eating Habits and Environmental Factors4.1.5 High Prevalence Rate of Rosacea4.2 Challenges4.2.1 Lack of Awareness4.2.2 Stringent Government Regulations4.3 Market Trends4.3.1 Approval of New Drugs 5. Competitive Landscape5.1 The U.S. Rosacea Market Players: A Financial Comparison5.2 The U.S. Rosacea Drugs Competitive Landscape5.3 The U.S. Rosacea Market Players Competitive Landscape 6. Company Profiles

  • Allergan Plc
  • Foamix Pharmaceuticals Ltd.
  • Galderma
  • Sol-Gel Technologies Ltd

For more information about this report visit https://www.researchandmarkets.com/r/6co82g

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content: http://www.prnewswire.com/news-releases/2020-insights-into-the-us-rosacea-market-profiles-of-key-players-including-allergan-galderma-and-sol-gel-technologies-301059618.html

SOURCE Research and Markets